<DOC>
	<DOCNO>NCT01165645</DOCNO>
	<brief_summary>RATIONALE : HIV protease inhibitor , include Lopinavir/Ritonavir intrinsic anti-apoptotic property addition anti-viral effect HIV . This anti-apoptotic effect may boost immune system help body create good immune response vaccine . PURPOSE : This randomized clinical trial study give lopinavir ritonavir together improve immune response vaccine patient complete remission follow bone marrow transplant Hodgkin lymphoma .</brief_summary>
	<brief_title>Lopinavir Ritonavir Improving Immune Response Vaccines Patients With Complete Remission Following A Bone Marrow Transplant Hodgkin Lymphoma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Compare TREC positive recent thymic emigrant , naive CD4+ CD8+ T cell number treatment group . SECONDARY OBJECTIVES : I . Compare post-vaccination anti-rabies antibody titer treatment group . II . Compare post-vaccination cytokine level , include IL1 , IL2 , IL4 , IL6 , IL7 , IL8 , IL10 , IL12 , INFgamma , TNFalpha , treatment group . III . Compare post-vaccination anti-rabies ELISPOT reaction treatment group . OUTLINE : Patients randomize 1 2 treatment arm . Arm I : Patients receive oral lopinavir oral ritonavir twice daily 28 day absence disease progression unacceptable toxicity . Arm II : Patients receive therapy . All patient receive neo-antigen rabies vaccine .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>Adult subject complete remission Day +100 bone marrow transplant Hodgkins Lymphoma Normal AST ALT , serum creatinine 12lead electrocardiogram within previous 6 month Females childbearing potential must negative betaHCG ( urine plasma ) within last month agree effective contraception course study Willingness ability give inform consent Willingness ability take pill twice day 28 day Known HIV positive Screening ALT AST great 3X upper limit normal Baseline QTc great 500 msec Current treatment immunosuppressive agent ( systemic glucocorticoid , cyclosporine , mycophenolate , azathioprine , sirolimus , Rituximab , infliximab , adalimumab ) Current treatment following : cisapride , ergot derivative , amiodarone , quinidine , terfenadine , astemizole , rifampin/rifabutin , carbamazepine , phenobarbital , sildenafil , St. John 's wort , azithromycin , carbamazepine , HIV antiviral , methadone , pimozide , phenytoin , sedative hypnotic ( midazolam , triazolam ) , HMGCoA reductase inhibitor ( lovastatin , simvastatin , atorvastatin ) Active malignancy require chemotherapy radiation Baseline creatinine &gt; 2.0 Active infection require systemic antiinfective agent ( exclude prophylactic antibiotic ) Hypersensitivity process bovine gelatin , chicken protein , neomycin , amphotericin B chlortetracycline Subject must medications interact metabolism protease inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
</DOC>